Please login to the form below

Not currently logged in


This page shows the latest licensing news and features for those working in and with pharma, biotech and healthcare.

Sanofi sells European generics to Advent for $2.4bn

Sanofi sells European generics to Advent for $2.4bn

Analysts suggest that Sanofi will re-invest the proceeds from the sale in its pipeline-building exercise, either through licensing deals or further acquisitions.

Latest news

More from news
Approximately 7 fully matching, plus 574 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    The companies were already partners having signed a $432m licensing deal in July 2016 for ex-US rights to Cx601 with double digit royalties due on net sales (DW Issue 73). ... Winding back to last February (DW Issue 80), Immunomedics announced a

  • Licensing

    Healthcare terms - Licensing.

  • Accelerating innovation Accelerating innovation

    Meanwhile, 2016 saw a licensing deal with Cabometyx (cabozantinib) from Californian biotech Exelixis and an agreement with 3B Pharmaceuticals to develop novel oncology radiopharmaceuticals. ... Partnering. Oncology naturally features prominently in

  • Pharma deals continue to slide Pharma deals continue to slide

    Licensing . The most common licensing deal is big pharma licensing in from biotech. ... 163. Mologen (DE). iPharma (CN). Binding term sheet for licensing and co-development.

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    access and uptake - will weigh more heavily on industry’s investment thinking than a more efficient licensing regime.

More from intelligence
Approximately 5 fully matching, plus 79 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 40 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...